Literature DB >> 23040363

Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.

Elana J Bernstein1, Christian Schmidt-Lauber, Jonathan Kay.   

Abstract

Nephrogenic systemic fibrosis (NSF) is an iatrogenic fibrosing disorder that primarily affects individuals with chronic kidney disease (CKD) following exposure to gadolinium-based contrast agents (GBCAs) during imaging procedures. NSF is characterised by skin thickening, tethering and hyperpigmentation; flexion contractures of joints; and extracutaneous fibrosis. This article reviews the history, clinical manifestations, epidemiology, histopathology and pathophysiology of this disabling disease.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23040363     DOI： 10.1016/j.berh.2012.07.008

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN： 1521-6942            Impact factor:   4.098


  16 in total

1.  Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis.

Authors:  Paco E Bravo; Amitoj Singh; Marcelo F Di Carli; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2018-11-02       Impact factor: 5.952

2.  Scleroderma Mimickers.

Authors:  Nadia D Morgan; Laura K Hummers
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-02-05

3.  Non-contrast MR angiography using three-dimensional balanced steady-state free-precession imaging for evaluation of stenosis in the celiac trunk and superior mesenteric artery: a preliminary comparative study with computed tomography angiography.

Authors:  Patricia P Cardia; Thiago J Penachim; Adilson Prando; Ulysses S Torres; Giuseppe D'Ippólito
Journal:  Br J Radiol       Date:  2017-06-07       Impact factor: 3.039

Review 4.  Radiological contrast media in the breastfeeding woman: a position paper of the Italian Society of Radiology (SIRM), the Italian Society of Paediatrics (SIP), the Italian Society of Neonatology (SIN) and the Task Force on Breastfeeding, Ministry of Health, Italy.

Authors:  Maria Assunta Cova; Fulvio Stacul; Roberto Quaranta; Pierpaolo Guastalla; Guglielmo Salvatori; Giuseppe Banderali; Claudio Fonda; Vincenzo David; Massimo Gregori; Antonio Alberto Zuppa; Riccardo Davanzo
Journal:  Eur Radiol       Date:  2014-05-17       Impact factor: 5.315

5.  Reduction of blood pressure by store-operated calcium channel blockers.

Authors:  Yan-Jun Xu; Vijayan Elimban; Naranjan S Dhalla
Journal:  J Cell Mol Med       Date:  2015-10-16       Impact factor: 5.310

6.  Manganese-containing Prussian blue nanoparticles for imaging of pediatric brain tumors.

Authors:  Matthieu F Dumont; Sridevi Yadavilli; Raymond W Sze; Javad Nazarian; Rohan Fernandes
Journal:  Int J Nanomedicine       Date:  2014-05-23

7.  Use of three-dimensional time-resolved phase-contrast magnetic resonance imaging with vastly undersampled isotropic projection reconstruction to assess renal blood flow in a renal cell carcinoma patient treated with sunitinib: a case report.

Authors:  Tatsuya Takayama; Yasuo Takehara; Masataka Sugiyama; Takayuki Sugiyama; Yasuo Ishii; Kevin E Johnson; Oliver Wieben; Tetsuya Wakayama; Harumi Sakahara; Seiichiro Ozono
Journal:  BMC Res Notes       Date:  2014-08-14

8.  Feasibility of measuring renal blood flow by phase-contrast magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease.

Authors:  E M Spithoven; E Meijer; C Borns; W E Boertien; C A J M Gaillard; P Kappert; M J W Greuter; E van der Jagt; P Vart; P E de Jong; R T Gansevoort
Journal:  Eur Radiol       Date:  2015-07-11       Impact factor: 5.315

9.  Proof of concept study: renal sympathetic denervation for treatment of polymorphic premature ventricular complexes.

Authors:  Márcio Galindo Kiuchi; Gustavo Ramalho E Silva; Luis Marcelo Rodrigues Paz; Shaojie Chen; Gladyston Luiz Lima Souto
Journal:  J Interv Card Electrophysiol       Date:  2016-05-30       Impact factor: 1.900

10.  Nephrogenic systemic fibrosis in Denmark--a nationwide investigation.

Authors:  Tina R Elmholdt; Anne B B Olesen; Bettina Jørgensen; Stinne Kvist; Lone Skov; Henrik S Thomsen; Peter Marckmann; Michael Pedersen
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.